These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8131209)

  • 1. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
    Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
    Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin.
    Debinski W; Puri RK; Kreitman RJ; Pastan I
    J Biol Chem; 1993 Jul; 268(19):14065-70. PubMed ID: 8314773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity.
    Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ
    Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
    Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
    J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
    Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
    Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein.
    Puri RK; Leland P; Kreitman RJ; Pastan I
    Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4.
    Debinski W; Obiri NI; Pastan I; Puri RK
    J Biol Chem; 1995 Jul; 270(28):16775-80. PubMed ID: 7622490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin.
    Debinski W; Puri RK; Pastan I
    Int J Cancer; 1994 Sep; 58(5):744-8. PubMed ID: 8077061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma.
    Kreitman RJ; Siegall CB; FitzGerald DJ; Epstein J; Barlogie B; Pastan I
    Blood; 1992 Apr; 79(7):1775-80. PubMed ID: 1558971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.
    Debinski W; Miner R; Leland P; Obiri NI; Puri RK
    J Biol Chem; 1996 Sep; 271(37):22428-33. PubMed ID: 8798406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
    Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
    Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
    Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.
    Gawlak SL; Pastan I; Siegall CB
    Bioconjug Chem; 1993; 4(6):483-9. PubMed ID: 7508267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.
    Puri RK
    Toxicol Pathol; 1999; 27(1):53-7. PubMed ID: 10367674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
    Kornmann M; Kleeff J; Debinski W; Korc M
    Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
    Ogata M; Chaudhary VK; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4215-9. PubMed ID: 2657746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes.
    Lorberboum-Galski H; Garsia RJ; Gately M; Brown PS; Clark RE; Waldmann TA; Chaudhary VK; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16311-7. PubMed ID: 1975810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.